The effect of GIP and glucagon-like peptides on intestinal basolateral membrane hexose transport
about
Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouseAction and therapeutic potential of oxyntomodulinMultifaceted interplay among mediators and regulators of intestinal glucose absorption: potential impacts on diabetes research and treatmentRapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagon-like peptide 2Gut adaptation and the glucagon-like peptidesThe role of gut hormones in glucose homeostasisGlucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice.Orexins control intestinal glucose transport by distinct neuronal, endocrine, and direct epithelial pathways.Growth factors: possible roles for clinical management of the short bowel syndrome.The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats.Intestinal sugar transport.Intestinal hormones and growth factors: effects on the small intestine.Treatment of suckling rats with GLP-2 plus dexamethasone increases the ileal uptake of fatty acids in later life.Diabetes mellitus and expression of the enterocyte renin-angiotensin system: implications for control of glucose transport across the brush border membrane.
P2860
Q22254347-8DFCA919-E580-4FB5-B248-4D35373D2C9AQ27025870-09143FAC-811F-4AA3-A577-FACF70A99C33Q28086792-2B90559B-031B-49A1-B5DF-2106540BE5B1Q28577695-49A2C495-7687-4B87-9031-5287EAE80480Q34526042-8338FA9A-7CA6-4389-B8CA-5A51E27E92DCQ35251016-3257E49A-D1FC-4D65-9C9E-BF0CB15DC5EEQ35596753-76534363-3607-4DF2-A523-AA871E250D9AQ36407410-4F806316-F400-4613-8302-51A4FED7151CQ37685500-A49AF69F-257B-4558-90A1-53E1447B2C38Q38101129-ECC70B02-F280-4F7F-985D-A83DCC0D62E1Q39974508-A4364BAC-1B5F-4E80-83CE-3A1F5CCB0E09Q42774246-67A84793-5655-46AD-A13C-ADFD513770D6Q43166019-2405713A-3843-4067-9398-E8C032CDCF3FQ45183078-7B5A706E-933F-4F90-AD82-929A1DC87B8CQ45964983-4FDEE297-64AC-4EF3-8EBE-9580DB1C848A
P2860
The effect of GIP and glucagon-like peptides on intestinal basolateral membrane hexose transport
description
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1996
@ast
im September 1996 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1996/09/01)
@sk
vědecký článek publikovaný v roce 1996
@cs
wetenschappelijk artikel (gepubliceerd op 1996/09/01)
@nl
наукова стаття, опублікована у вересні 1996
@uk
مقالة علمية (نشرت في سبتمبر 1996)
@ar
name
The effect of GIP and glucagon ...... eral membrane hexose transport
@ast
The effect of GIP and glucagon ...... eral membrane hexose transport
@en
The effect of GIP and glucagon ...... eral membrane hexose transport
@nl
type
label
The effect of GIP and glucagon ...... eral membrane hexose transport
@ast
The effect of GIP and glucagon ...... eral membrane hexose transport
@en
The effect of GIP and glucagon ...... eral membrane hexose transport
@nl
prefLabel
The effect of GIP and glucagon ...... eral membrane hexose transport
@ast
The effect of GIP and glucagon ...... eral membrane hexose transport
@en
The effect of GIP and glucagon ...... eral membrane hexose transport
@nl
P1476
The effect of GIP and glucagon ...... eral membrane hexose transport
@en
P2093
C. I. Cheeseman
P304
P356
10.1152/AJPGI.1996.271.3.G477
P407
P433
P577
1996-09-01T00:00:00Z